242 related articles for article (PubMed ID: 22706513)
1. Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones.
Novais A; Rodrigues C; Branquinho R; Antunes P; Grosso F; Boaventura L; Ribeiro G; Peixe L
Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3057-63. PubMed ID: 22706513
[TBL] [Abstract][Full Text] [Related]
2. Expansion of ESBL-producing Klebsiella pneumoniae in hospitalized patients: a successful story of international clones (ST15, ST147, ST336) and epidemic plasmids (IncR, IncFIIK).
Rodrigues C; Machado E; Ramos H; Peixe L; Novais Â
Int J Med Microbiol; 2014 Nov; 304(8):1100-8. PubMed ID: 25190354
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.
Doumith M; Ellington MJ; Livermore DM; Woodford N
J Antimicrob Chemother; 2009 Apr; 63(4):659-67. PubMed ID: 19233898
[TBL] [Abstract][Full Text] [Related]
4. Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant.
Poulou A; Voulgari E; Vrioni G; Koumaki V; Xidopoulos G; Chatzipantazi V; Markou F; Tsakris A
J Clin Microbiol; 2013 Oct; 51(10):3176-82. PubMed ID: 23850951
[TBL] [Abstract][Full Text] [Related]
5. Role of association of OmpK35 and OmpK36 alteration and bla
Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I
Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and molecular characteristics of carbapenem-non-susceptible Enterobacteriaceae from a teaching hospital in Wenzhou, southern China.
Zhou T; Zhang X; Guo M; Ye J; Lu Y; Bao Q; Chi W
Jpn J Infect Dis; 2013; 66(2):96-102. PubMed ID: 23514904
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization and antimicrobial susceptibility of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae isolates at a tertiary-care centre in Monterrey, Mexico.
Garza-González E; Mendoza Ibarra SI; Llaca-Díaz JM; Gonzalez GM
J Med Microbiol; 2011 Jan; 60(Pt 1):84-90. PubMed ID: 20930052
[TBL] [Abstract][Full Text] [Related]
8. Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency.
Wang XD; Cai JC; Zhou HW; Zhang R; Chen GX
J Med Microbiol; 2009 Sep; 58(Pt 9):1196-1202. PubMed ID: 19528170
[TBL] [Abstract][Full Text] [Related]
9. Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobacteriaceae.
Little ML; Qin X; Zerr DM; Weissman SJ
Int J Antimicrob Agents; 2012 Jan; 39(1):52-7. PubMed ID: 22055532
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789).
Del Franco M; Paone L; Novati R; Giacomazzi CG; Bagattini M; Galotto C; Montanera PG; Triassi M; Zarrilli R
BMC Microbiol; 2015 Nov; 15(1):260. PubMed ID: 26552763
[TBL] [Abstract][Full Text] [Related]
11. Porin alterations present in non-carbapenemase-producing Enterobacteriaceae with high and intermediate levels of carbapenem resistance in Chile.
Wozniak A; Villagra NA; Undabarrena A; Gallardo N; Keller N; Moraga M; Román JC; Mora GC; García P
J Med Microbiol; 2012 Sep; 61(Pt 9):1270-1279. PubMed ID: 22700549
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the Genetic Background of KPC-2-Producing
Wu LT; Guo MK; Ke SC; Lin YP; Pang YC; Nguyen HV; Chen CM
Microb Drug Resist; 2020 Sep; 26(9):1050-1057. PubMed ID: 32283046
[TBL] [Abstract][Full Text] [Related]
13. Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.
Netikul T; Kiratisin P
PLoS One; 2015; 10(9):e0139116. PubMed ID: 26407326
[TBL] [Abstract][Full Text] [Related]
14. Emergence of Enterobacteriaceae co-producing CTX-M-15, ArmA and PMQR in Poland.
Piekarska K; Zacharczuk K; Wołkowicz T; Wolaniuk N; Rzeczkowska M; Gierczyński R
Adv Clin Exp Med; 2019 Feb; 28(2):249-254. PubMed ID: 30499638
[TBL] [Abstract][Full Text] [Related]
15. An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia.
Hamzaoui Z; Ocampo-Sosa A; Maamar E; Fernandez Martinez M; Ferjani S; Hammami S; Harbaoui S; Genel N; Arlet G; Saidani M; Slim A; Boutiba-Ben Boubaker I; Martinez-Martinez L
Microb Drug Resist; 2018 Oct; 24(8):1137-1147. PubMed ID: 29373087
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 β-lactamase production in Japan.
Sho T; Muratani T; Hamasuna R; Yakushiji H; Fujimoto N; Matsumoto T
Microb Drug Resist; 2013 Aug; 19(4):274-81. PubMed ID: 23514607
[TBL] [Abstract][Full Text] [Related]
17. Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values.
Castanheira M; Doyle TB; Hubler C; Sader HS; Mendes RE
Int J Antimicrob Agents; 2020 Jul; 56(1):106011. PubMed ID: 32417206
[TBL] [Abstract][Full Text] [Related]
18. Outbreak of KPC-3-producing ST15 and ST348 Klebsiella pneumoniae in a Portuguese hospital.
Vubil D; Figueiredo R; Reis T; Canha C; Boaventura L; DA Silva GJ
Epidemiol Infect; 2017 Feb; 145(3):595-599. PubMed ID: 27788691
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development.
Mena A; Plasencia V; García L; Hidalgo O; Ayestarán JI; Alberti S; Borrell N; Pérez JL; Oliver A
J Clin Microbiol; 2006 Aug; 44(8):2831-7. PubMed ID: 16891499
[TBL] [Abstract][Full Text] [Related]
20. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe.
Kaczmarek FM; Dib-Hajj F; Shang W; Gootz TD
Antimicrob Agents Chemother; 2006 Oct; 50(10):3396-406. PubMed ID: 17005822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
